MBCOF.US Marvel Biosciences Corp.

Healthcare Biotechnology USA Stocks
0.0900 USD
Close of Nov 17, 2026
0.0722 0.1721
Market cap
USD 6.63M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Apr 2026.

Is MBCOF.US undervalued?

Graham number

The Graham number of Marvel Biosciences Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Marvel Biosciences Corp. fundamental analysis

No fundamental analysis for Marvel Biosciences Corp. yet.

Marvel Biosciences Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Marvel Biosciences Corp.

Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Ca…

Full company profile